期刊文献+

重组腺病毒气管途径反复转染大鼠肺组织人类eNOS基因的转导效果

Efficiency of transduction of recombinant adenovirus-mediated human endothelial nitric oxide synthase gene into lung tissue by repeated intratracheal transfection in rats
原文传递
导出
摘要 目的重组腺病毒气管途径反复转染大鼠肺组织人类内皮型一氧化氮合酶(eNOS)基因的转导效果。方法雄性Wistar大鼠60只,3~4月龄,体重220—280g,采用随机数字表法,将其随机分为2组:对照组(C组,n=10)和重组eNOS基因转染组(T组,n=50)。麻醉下,气管插管,行机械通气,T组气管内注射滴度为5×109PFU/ml的携带人类eNOS基因的重组腺病毒载体质粒DNA50μl,c组注射等容量病毒保存液,每隔5min重复经气管内注射一次,共注射12次。T组分别于转染后2、5、7、14、21d时取10只大鼠,采集肺动脉血样,采用硝酸还原酶法测定血清NO浓度,分别采用WesternNot法及荧光定量PCR技术检测肺组织eNOS其及RNA表达,采用免疫组化法测定气管、支气管、肺、肝、脾、肾组织eNOS表达。结果与c组比较,T组各时点肺动脉血清NO浓度、肺组织eNOS及其RNA表达升高(P〈0.05);转染后7、14和21d时明显高于转染后2d(P〈0.05)。T组气管、支气管上皮细胞、肺泡囊内细胞和肺内小血管的内皮细胞均有eNOS表达,而c组未见eNOS表达。转染后7d时肝、脾、肾组织未见eNOS表达。结论重组腺病毒气管途径反复转染大鼠肺组织人类eNOS基因后,可实现外源基因在肺内表达,且具有正常的酶活性,无远隔器官表达。 Objective To investigate the efficiency of transduction of recombinant adenovirus-mediated human endothelial nitric oxide synthase (eNOS) into lung tissue by repeated intratracheal transfection in rats. Methods Sixty 3-4 month old male Wistar rats weighing 220-280 g were randomly divided into 2 groups: control group (group C, n -- 10) and eNOS gene transduction group (group T, n = 50). The animals were anesthetized with intraperitoneal 10% chloral hydrate 35 mg/kg, traeheally intuhated and mechanically ventilated (VT 2.5 ml, RR 60 bpm, FiO2 1.0). Recombinant adenovirus carrying human eNOS gene was given as gift by Professor Gerard from Texas University, Southwest Medical Center. In group T 50 μl of the recombinant adenovirus in concentration of.5 × 109 PFU/ml was instilled into trachea every 5 minutes for 12 times, while in group C equal volume of vector conservation solution was instilled instead. Pulmonary arterial blood samples were obtained at 2, 5, 7, 14 and 21 d after intratracheal transfection ( n = 10 at each time point) for determination of serum NO concentration. The ani- mals were immediately sacrificed after blood sample collection for determination of expression of eNOS protein in the lung tissue and RNA. The eNOS expression in the trachea, bronchus, lung, liver, spleen and kidney was detected by immuno-histochemistry.Results The serum NO concentrations were significantly higher at all time points in group T than in group C. The eNOS expression was detected in the epithelial cells of trachea and bronchi, and en- dothelial cells of alveoli and pulmonary blood vessels in group T but not in group C. eNOS expression was not deteeted in liver, spleen and kidney at 7 d after intratracheal transfection in group T. Conclusion Human eNOS gene mediated by recombinant adenovirus was transdueted into rat lung tissue with normal enzyme activity by re- peated intratracheal administration without being detected in distant organs.
出处 《中华麻醉学杂志》 CAS CSCD 北大核心 2012年第8期999-1001,共3页 Chinese Journal of Anesthesiology
关键词 一氧化氮合酶Ⅲ型 腺病毒科 基因转移技术 Nitric oxide synthase type m Adenoviridae Lung Gene transfer techniques
  • 相关文献

参考文献7

  • 1Steudel W, Ichinose F, Huang PL, et al. Pulmonary vasoconstriction and hypertension in mice with targeted disruption of the endothelial nitric oxide synthase( NOS 3 ) gene. Cite Res, 1997,81 ( 1 ) : 34-41.
  • 2周锦,王俊科,张铁铮,金强,张毅男,王凤学.eNOS基因转染对慢性缺氧性肺动脉高压的影响[J].第四军医大学学报,2006,27(18):1671-1674. 被引量:7
  • 3Rha SJ, Wang YP. Enhanced expressions and histological characteris- tics of intravenously administered plasmid DNA in rat lung. J Koreae- an Med Sci,2001,16(5) :567-572.
  • 4Huard J, Lochmuller H, Acsadi G. The route of administration is a major determinant of the transduction efficiency of rat tissues by ade- noviral recombinants. Gerte Ther, 1995,2(2) : 107-115.
  • 5Janssens SP, Bloch KD, Nong Z, et al. Adenoviral-mediated transfer of the human endothelial nitric oxide synthase gene reduces acute hy- poxic pulmonary vasoconstriction in rats. Clin Invest, 1996,98 (2): 317-324.
  • 6Zhang F, Wu S, Lu X, et al. Gene transfer of endothelial nitric ox- ide synthase attenuates flow-induced pulmonary hypertension in rab- bits. Ann Thorac Surg,2008,85(2) :581-585.
  • 7Janssens SP, Shimouchi A, Quertermous T, et al. Cloning and ex- pression of a cDNA encoding human endothelium-derived relaxing factor/nitric oxide synthase. J Biol Chem, 1992,267(21):14519- 14522.

二级参考文献7

  • 1Dembinski R. Pulmonary hypertension [J]. Anaesthesist, 2006,55(2) :195 -214.
  • 2Nakamoto T, Harasawa H, Fuse D, et al. Nitric oxide and pulmonaryhy pertension [J]. Nippon Rinsho, 2004,62 : ( Suppl 9 ) :522 - 526.
  • 3Han RN, Stewart DJ. Defective lung vascular development in endothelial nitric oxide synthase-deficient mice[J]. Trends Cardiovasc Med, 2006,16(1) :29-34.
  • 4Fojon S, Fernandez-Gonzalez C, Sanchez-Andrade J, et al. Inhaled nitric oxide through a noninvasive ventilation device to assess reversibility of pulmonary hypertension in selecting recipients for heart transplant[J]. Chest, 2005.128(6 Suppl):614-618
  • 5Konduri GG, Ou J, Shi Y, et al. Decreased association of HSP90 impairs endothelial nitric oxide synthase in fetal lambs with persistent pulmonary hypertension[J]. Am J Physiol Heart Cire Physiol,2003,285 ( 1 ) : H204 - 211.
  • 6Dai ZK, Tan MS, Chai CY, et al. Upregulation of endothelial nitric oxide synthase and endothelin-1 in pulmonary hypertension secondary to heart failure in aorta-banded rats [J]. Pediatr Pulmonol, 2004,37 (3) :249 - 256.
  • 7Lee AJ, Chiao TB, Tsang MP. Sildenafil for pulmonary hypertension[J]. Ann Pharmacother, 2005,39:869 - 884.

共引文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部